Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1551.6000 10.40 (0.67%)
NSE Sep 09, 2025 15:31 PM
Volume: 788.2K
 

logo
Cipla Ltd.
08 Feb 2018, 12:00AM
1551.60
0.67%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 7% YoY to | 3914 crore, (I-direct estimate: | 4167 crore) mainly due to 15% growth in the domestic formulations to | 1601 crore (I-direct estimate: | 1677 crore). EBITDA margins improved 234 bps YoY to 20.9%, and came above Idirect estimate of 20.3% mainly due higher gross margins (64.8% vs I-Direct estimates of 64%). EBITDA grew 21% YoY to | 819 crore (Idirect estimate: | 846 crore) PAT grew 7% to | 401 crore (I-direct estimate: | 482 crore) as higher operational performance YoY was largely negated by | 174 crore of...
Cipla Ltd. has an average target of 1702.60 from 10 brokers.
More from Cipla Ltd.
Recommended